138 related articles for article (PubMed ID: 12861040)
1. TNP-470 inhibits 7,12-dimethylbenz[a]anthracene-induced mammary tumor formation when administered before the formation of carcinoma in situ but is not additive with tamoxifen.
Heffelfinger SC; Gear RB; Schneider J; LaDow K; Yan M; Lu F; Pyle AL; Warshawsky D
Lab Invest; 2003 Jul; 83(7):1001-11. PubMed ID: 12861040
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of VEGFR2 prevents DMBA-induced mammary tumor formation.
Heffelfinger SC; Yan M; Gear RB; Schneider J; LaDow K; Warshawsky D
Lab Invest; 2004 Aug; 84(8):989-98. PubMed ID: 15170218
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
4. DMBA-induced mammary pathologies are angiogenic in vivo and in vitro.
Heffelfinger SC; Gear RB; Taylor K; Miller MA; Schneider J; LaDow K; Warshawsky D
Lab Invest; 2000 Apr; 80(4):485-92. PubMed ID: 10780665
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiogenesis inhibitor TNP-470 on tamoxifen-stimulated MCF-7 breast tumors in nude mice.
Takei H; Lee ES; Cisneros A; Jordan VC
Cancer Lett; 2000 Jul; 155(2):129-35. PubMed ID: 10822127
[TBL] [Abstract][Full Text] [Related]
6. 4-(hydroxyphenyl)retinamide selectively inhibits the development and progression of ductal hyperplastic lesions and carcinoma in situ in mammary gland.
Green A; Shilkaitis A; Christov K
Carcinogenesis; 1999 Aug; 20(8):1535-40. PubMed ID: 10426803
[TBL] [Abstract][Full Text] [Related]
7. Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.
Benakanakere I; Besch-Williford C; Carroll CE; Hyder SM
Cancer Prev Res (Phila); 2010 Sep; 3(9):1157-67. PubMed ID: 20699413
[TBL] [Abstract][Full Text] [Related]
8. Characterization of TNP-470-induced modifications to cell functions in HUVEC and cancer cells.
Farinelle S; Malonne H; Chaboteaux C; Decaestecker C; Dedecker R; Gras T; Darro F; Fontaine J; Atassi G; Kiss R
J Pharmacol Toxicol Methods; 2000; 43(1):15-24. PubMed ID: 11091126
[TBL] [Abstract][Full Text] [Related]
9. Purple grape juice inhibits 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation.
Jung KJ; Wallig MA; Singletary KW
Cancer Lett; 2006 Feb; 233(2):279-88. PubMed ID: 15878797
[TBL] [Abstract][Full Text] [Related]
10. Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis.
Takatsuka S; Yamada N; Sawada T; Ogawa Y; Maeda K; Ohira M; Ishikawa T; Nishino H; Seki S; Hirakawa-YS Chung K
Int J Oncol; 2000 Aug; 17(2):253-8. PubMed ID: 10891532
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of liver metastases by the anti-angiogenic drug TNP-470.
Gervaz P; Scholl B; Padrun V; Gillet M
Liver; 2000 Apr; 20(2):108-13. PubMed ID: 10847478
[TBL] [Abstract][Full Text] [Related]
12. Expression of angiogenic factors is upregulated in DMBA-induced rat mammary pathologies.
Yan M; Schneider J; Gear R; Lu F; LaDow K; Warshawsky D; Heffelfinger SC
Pathobiology; 2004; 71(5):253-60. PubMed ID: 15459484
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor growth and metastasis by angiogenesis inhibitor TNP-470 on breast cancer cell lines in vitro and in vivo.
Singh Y; Shikata N; Kiyozuka Y; Nambu H; Morimoto J; Kurebayashi J; Hioki K; Tsubura A
Breast Cancer Res Treat; 1997 Aug; 45(1):15-27. PubMed ID: 9285113
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
[TBL] [Abstract][Full Text] [Related]
15. An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma.
Murata R; Nishimura Y; Hiraoka M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1107-13. PubMed ID: 9169820
[TBL] [Abstract][Full Text] [Related]
16. PSK (krestin) potentiates chemotherapeutic effects of tamoxifen on rat mammary carcinomas.
Iino Y; Takai Y; Sugamata N; Morishita Y
Anticancer Res; 1992; 12(6B):2101-3. PubMed ID: 1295453
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis inhibitor TNP-470 suppresses the progression of experimentally-induced hepatocellular carcinoma in rats.
Kin M; Torimura T; Ueno T; Nakamura T; Ogata R; Sakamoto M; Tamaki S; Sata M
Int J Oncol; 2000 Feb; 16(2):375-82. PubMed ID: 10639583
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of modeling effects of two different 7, 12-dimethylbenz[a] anthracene induced breast cancer models in tree shrew].
Mao AY; Chen MJ; Yang C; Ou C; Ye XQ; Qin QH; Mo M; Wei CY
Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):346-350. PubMed ID: 31137167
[No Abstract] [Full Text] [Related]
19. Trianthema portulacastrum Linn. exerts chemoprevention of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats.
Bishayee A; Mandal A
Mutat Res; 2014 Oct; 768():107-18. PubMed ID: 24451939
[TBL] [Abstract][Full Text] [Related]
20. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
Thun-Battersby S; Mevissen M; Löscher W
Cancer Res; 1999 Aug; 59(15):3627-33. PubMed ID: 10446973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
